HHS Secretary nominee Robert F. Kennedy Jr. will divest his interests in several biopharma companies, including CRISPR Therapeutics and Dragonfly Therapeutics, if confirmed by the
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Rob Califf officially ends his tenure as FDA commissioner on Monday, but in his final media event, he stressed that the US is still struggling
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Rarely does the FDA publicly release its reasoning for rejecting a potential new drug. But for DC-based Vanda Pharmaceuticals’ gastroparesis drug, the FDA on Wednesday
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
The top three pharmacy benefit managers hiked the prices of dozens of “specialty” generic drugs, some by more than 1,000% of their acquisition cost, the
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, will step down, the agency confirmed Friday. An email was sent to employees